PRODUCT DETAIL

Folgan HCT 40 mg/10 mg/25 mg

Code

04684

MA number

58/0038/11-S

Product Form:

tbl flm 30x40 mg/10 mg/25 mg (fľ.HDPE)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

MAH, country:

Menarini International Operations Luxembourg S.A., Luxembourg

Therapeutic Class:

58 - HYPOTENSIVA

ATC:

C	CARDIOVASCULAR SYSTEM
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D	ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
C09DX	Angiotensin II antagonists, other combinations
C09DX03	Olmesartan medoxomil, amlodipine and hydrochlorothiazide

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10b fixed combination application
MA issued:	09.02.2011
Pediatric warnings:	Yes
PIL:	PIL_Folgan HCT_12/2022.pdf
SPC:	SPC_Folgan HCT_09/2023.pdf
Safety feature	Yes
Data update:	08.01.2018